Neural Tube Defects in the Neonatal Period Workup

  • Author: Richard G Ellenbogen, MD; Chief Editor: Ted Rosenkrantz, MD   more...
 
Updated: Jan 26, 2012
 

Laboratory Studies

Presence of open neural tube defects (NTDs) can be detected with the measurement of AFP in the amniotic fluid or maternal bloodstream. AFP is the major serum protein in early embryonic life and is 90% of the total serum globulin in a fetus. It is believed to be involved in preventing fetal immune rejection and is first made in the yolk sac and then later in the GI system and liver of the fetus. It goes from the fetal blood stream to the fetal urinary tract, where it is excreted into the maternal amniotic fluid. The AFP can also leak into the amniotic fluid from open neural tube defects such as anencephaly and myelomeningocele, in which the fetal blood stream is in direct contact with the amniotic fluid.

The first step in prenatal screening is measuring the maternal serum AFP at 15-20 weeks' gestation. A patient-specific risk is then calculated based on gestational age and AFP level. For example, at 20 weeks' gestation, a maternal serum AFP concentration higher than 1,000 ng/mL would be indicative of an open neural tube defect. Normal AFP concentration in the maternal serum is usually lower than 500 ng/mL.

Determining precise gestational age is essential because fetal AFP levels are age specific and can peak in a normal fetus at 12-15 weeks' gestation. The measurement of maternal serum AFP levels is more than 75% accurate in detecting an open neural tube defect at more than 15 weeks' gestation. In patients in whom a question persists, amniotic AFP can be obtained. It is a significantly more accurate test, especially at 15-20 weeks' gestation, and detects approximately 98% of all open neural tube defects, although this method is not the preferred screening test. Amniotic fluid acetylcholinesterase levels add an increased degree of resolution.

A partial list of the fetal anomalies that are associated with elevated AFP levels is as follows:

  • Anencephaly
  • Spina bifida cystica
  • Encephalocele (leaking)
  • Conjoined twins
  • Omphalocele
  • Turner syndrome
  • Gastroschisis
  • Exstrophy of the cloaca
  • Oligohydramnios
  • Sacrococcygeal teratoma
  • Polycystic kidneys
  • Fetal death
  • Urinary tract obstruction
Next

Imaging Studies

Detection of a neural tube defect with fetal ultrasonography in the hands of a skilled ultrasonographer is usually 98% specific. False-positive findings can result from multiple pregnancies or inaccurate fetal dating. However, closed neural tube defects can sometimes remain undetected, especially in cases of skin-covered lipomyelomeningoceles and meningoceles, in which the AFP levels may also be normal. These closed neural tube defects comprise about 10% or more of total neural tube defects discovered. A skilled ultrasonographer can detect these lesions with almost 95% sensitivity.

Previous
Proceed to Treatment & Management
 
 
Contributor Information and Disclosures
Author

Richard G Ellenbogen, MD  Professor and Chairman, Theodore S Roberts Endowed Chair in Pediatric Neurosurgery, Department of Neurological Surgery, University of Washington

Richard G Ellenbogen, MD is a member of the following medical societies: American College of Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Shelley C Springer, MD, MBA, MSc, JD, FAAP  Clinical Instructor, Department of Pediatrics, University of Vermont College of Medicine; Clinical Instructor, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health; Neonatologist, Pediatrix Medical Group; Assistant Clinical Professor, Department of Pediatrics, University of North Texas Science Center; Assistant Clinical Professor, Department of Pediatrics, Texas A&M Health Science Center College of Medicine

Shelley C Springer, MD, MBA, MSc, JD, FAAP is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Brian S Carter, MD, FAAP  Professor of Pediatrics (Neonatology), Vanderbilt University School of Medicine; Director, Neonatal Follow-up Program, Monroe Carell Jr Children's Hospital at Vanderbilt

Brian S Carter, MD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Hospice and Palliative Medicine, American Academy of Pediatrics, American Society for Bioethics and Humanities, American Society of Law, Medicine & Ethics, National Hospice and Palliative Care Organization, Society for Pediatric Research, and Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Carol L Wagner, MD  Professor of Pediatrics, Medical University of South Carolina

Carol L Wagner, MD is a member of the following medical societies: American Academy of Pediatrics, American Chemical Society, American Medical Women's Association, American Public Health Association, American Society for Bone and Mineral Research, American Society for Clinical Nutrition, Massachusetts Medical Society, National Perinatal Association, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD  Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine

Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, American Pediatric Society, Connecticut State Medical Society, Eastern Society for Pediatric Research, and Society for Pediatric Research

Disclosure: Nothing to disclose.

References

  1. Dudar JC. Qualitative and quantitative diagnosis of lethal cranial neural tube defects from the fetal and neonatal human skeleton, with a case study involving taphonomically altered remains. J Forensic Sci. Jul 2010;55(4):877-83. [Medline].

  2. Lemire RJ, Beckwith JB, Warkany J. Anencephaly. New York, NY: Raven Press; 1978:1-271.

  3. De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. Jul 12 2007;357(2):135-42. [Medline].

  4. Blencowe H, Cousens S, Modell B, Lawn J. Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol. Apr 2010;39 Suppl 1:i110-21. [Medline]. [Full Text].

  5. Bulbul A, Can E, Bulbul LG, Cömert S, Nuhoglu A. Clinical characteristics of neonatal meningomyelocele cases and effect of operation time on mortality and morbidity. Pediatr Neurosurg. 2010;46(3):199-204. [Medline].

  6. McLone DG, Naidich TP. Developmental morphology of the subarachnoid space, brain vasculature, and contiguous structures, and the cause of the Chiari II malformation. AJNR Am J Neuroradiol. Mar-Apr 1992;13(2):463-82. [Medline].

  7. Smithells RW, Sheppard S, Schorah CJ. Vitamin dificiencies and neural tube defects. Arch Dis Child. Dec 1976;51(12):944-50. [Medline].

  8. Smithells RW, Sheppard S, Schorah CJ, et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child. Dec 1981;56(12):911-8. [Medline].

  9. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet. Feb 16 1980;1(8164):339-40. [Medline].

  10. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet. Jul 20 1991;338(8760):131-7. [Medline].

  11. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. Dec 24 1992;327(26):1832-5. [Medline].

  12. Bjorklund NK, Gordon R. A hypothesis linking low folate intake to neural tube defects due to failure of post-translation methylations of the cytoskeleton. Int J Dev Biol. 2006;50(2-3):135-41. [Medline].

  13. Botto LD, Lisi A, Robert-Gnansia E, et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?. BMJ. Mar 12 2005;330(7491):571. [Medline].

  14. Canfield MA, Collins JS, Botto LD, et al. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol. Oct 2005;73(10):679-89. [Medline].

  15. Grewal J, Carmichael SL, Ma C, Lammer EJ, Shaw GM. Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies. Birth Defects Res A Clin Mol Teratol. Jul 2008;82(7):519-26. [Medline].

  16. Shurtleff D, Lemire R, Warkany J. Embryology, etiology, and epidemiology. In: Myelodysplasias and Exstrophies: Significance, Prevention and Treatments. New York, NY: WB Saunders Co; 1986:39-64.

  17. McLone DG. Continuing concepts in the management of spina bifida. Pediatr Neurosurg. 1992;18(5-6):254-6. [Medline].

  18. McLone DG, Czyzewski D, Raimondi AJ, Sommers RC. Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocele. Pediatrics. 70:338-342.

  19. Shurtleff DB, Lemire RJ. Epidemiology, etiologic factors, and prenatal diagnosis of open spinal dysraphism. Neurosurg Clin N Am. Apr 1995;6(2):183-93. [Medline].

  20. Charney EB, Weller SC, Sutton LN, Bruce DA, Schut LB. Management of the newborn with myelomeningocele: time for a decision-making process. Pediatrics. Jan 1985;75(1):58-64. [Medline].

  21. Bruner JP, Tulipan N, Paschall RL, et al. Fetal surgery for myelomeningocele and the incidence of shunt-dependent hydrocephalus. JAMA. Nov 17 1999;282(19):1819-25. [Medline].

  22. Adzick NS, Sutton LN, Crombleholme TM, Flake AW. Successful fetal surgery for spina bifida. Lancet. Nov 21 1998;352(9141):1675-6. [Medline].

  23. Fichter MA, Dornseifer U, Henke J, et al. Fetal spina bifida repair--current trends and prospects of intrauterine neurosurgery. Fetal Diagn Ther. 2008;23(4):271-86. [Medline].

  24. Laurence KM. Effect of early surgery for spina bifida cystica on survival and quality of life. Lancet. Feb 23 1974;1(7852):301-4. [Medline].

  25. Lorber J, Salfield SA. Results of selective treatment of spina bifida cystica. Arch Dis Child. Nov 1981;56(11):822-30. [Medline].

  26. Steinbok P, Irvine B, Cochrane DD, Irwin BJ. Long-term outcome and complications of children born with meningomyelocele. Childs Nerv Syst. Mar 1992;8(2):92-6. [Medline].

  27. Aubry MC, Aubry JP, Dommergues M. Sonographic prenatal diagnosis of central nervous system abnormalities. Childs Nerv Syst. Aug 2003;19(7-8):391-402. [Medline].

  28. Coffey VP. Neural tube defects in Dublin 1953-1954 and 1961-1982. Ir Med J. Oct 1983;76(10):411-3. [Medline].

  29. Copp AJ. Neurulation in the cranial region--normal and abnormal. J Anat. Nov 2005;207(5):623-35. [Medline].

  30. Economic burden of spina bifida--United States, 1980-1990. MMWR Morb Mortal Wkly Rep. Apr 21 1989;38(15):264-7. [Medline].

  31. Harvey MH, Morris BA, McMillan M, Marks V. Potato steroidal alkaloids and neural tube defects: serum concentrations fail to demonstrate a causal relation. Hum Toxicol. Jul 1986;5(4):249-53. [Medline].

  32. Hunt GM, Holmes AE. Factors relating to intelligence in treated cases of spina bifida cystica. Am J Dis Child. Aug 1976;130(8):823-7. [Medline].

  33. Lemire RJ. Neural tube defects. JAMA. Jan 22-29 1988;259(4):558-62. [Medline].

  34. Li ZW, Ren AG, Zhang L, et al. [Prevalence of major external birth defects in high and low risk areas in China, 2003]. Zhonghua Liu Xing Bing Xue Za Zhi. Apr 2005;26(4):252-7. [Medline].

  35. Lindhout D, Omtzigt JG. Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. Epilepsia. 1994;35 Suppl 4:S19-28. [Medline].

  36. Lorber J, Ward AM. Spina bifida--a vanishing nightmare?. Arch Dis Child. Nov 1985;60(11):1086-91. [Medline].

  37. Luthy DA, Wardinsky T, Shurtleff DB, et al. Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally. N Engl J Med. Mar 7 1991;324(10):662-6. [Medline].

  38. MacMahon B, Yen S, Rothman KJ. Potato blight and neural-tube defects. Lancet. Mar 17 1973;1(7803):598-9. [Medline].

  39. Mangels KJ, Tulipan N, Tsao LY, Alarcon J, Bruner JP. Fetal MRI in the evaluation of intrauterine myelomeningocele. Pediatr Neurosurg. Mar 2000;32(3):124-31. [Medline].

  40. Marín-Padilla M. Cephalic axial skeletal-neural dysraphic disorders: embryology and pathology. Can J Neurol Sci. May 1991;18(2):153-69. [Medline].

  41. Menkes JH, Sarnat HB, eds. Malformations of the Central Nervous Sytem. In: Child Neurology. 7th ed. Lippincott Williams & Wilkins; 2005:305-31.

  42. Mills JL, Conley MR. Periconceptional vitamin supplementation to prevent neural tube defects: how can we do it?. Eur J Obstet Gynecol Reprod Biol. Jul 1995;61(1):49-55. [Medline].

  43. Morales PA. Urologic management of children with myelomeningocele. Med Clin North Am. May 1969;53(3):496-501. [Medline].

  44. Moskowitz D, Shurtleff DB, Weinberger E, Loeser J, Ellenbogen R. Anatomy of the spinal cord in patients with meningomyelocele with and without hypoplasia or hydromyelia. Eur J Pediatr Surg. Dec 1998;8 Suppl 1:18-21. [Medline].

  45. Naggan L, MacMahon B. Ethnic differences in the prevalence of anencephaly and sina bifida in Boston, Massachusetts. N Engl J Med. Nov 23 1967;277(21):1119-23. [Medline].

  46. Park TS. Myelomeningocele. In: Principles and Practice of Pediatric Neurosurgery. Thieme Medical Publishers: 1999:291-320.

  47. Roberts HE, Moore CA, Cragan JD, Fernhoff PM, Khoury MJ. Impact of prenatal diagnosis on the birth prevalence of neural tube defects, Atlanta, 1990-1991. Pediatrics. Nov 1995;96(5 Pt 1):880-3. [Medline].

  48. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med. Mar 7 1991;324(10):674-7. [Medline].

  49. Smith MS, Edwards MJ, Upfold JB. The effects of hyperthermia on the fetus. Dev Med Child Neurol. Dec 1986;28(6):806-9. [Medline].

  50. Stein SC, Feldman JG, Friedlander M, Klein RJ. Is myelomeningocele a disappearing disease?. Pediatrics. May 1982;69(5):511-4. [Medline].

  51. Sutton LN, Adzick NS, Bilaniuk LT, Johnson MP, Crombleholme TM, Flake AW. Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelomeningocele. JAMA. Nov 17 1999;282(19):1826-31. [Medline].

  52. Tulipan N, Bruner JP. Myelomeningocele repair in utero: a report of three cases. Pediatr Neurosurg. Apr 1998;28(4):177-80. [Medline].

  53. Tulipan N, Hernanz-Schulman M, Bruner JP. Reduced hindbrain herniation after intrauterine myelomeningocele repair: A report of four cases. Pediatr Neurosurg. Nov 1998;29(5):274-8. [Medline].

  54. Tulipan N, Hernanz-Schulman M, Lowe LH, Bruner JP. Intrauterine myelomeningocele repair reverses preexisting hindbrain herniation. Pediatr Neurosurg. Sep 1999;31(3):137-42. [Medline].

  55. Yates JR, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, Clark BJ. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects?. Clin Genet. May 1987;31(5):279-87. [Medline].

  56. Yen IH, Khoury MJ, Erickson JD, James LM, Waters GD, Berry RJ. The changing epidemiology of neural tube defects. United States, 1968-1989. Am J Dis Child. Jul 1992;146(7):857-61. [Medline].

 
Previous
Next
 
Neonate with a lumbar myelomeningocele with an L5 neurologic level. Note the diaphanous sac filled with cerebrospinal fluid and containing fragile vessels in its membrane. Also, note the neural placode plastered to the dorsal surface of the sac. This patient underwent closure of his back and an untethering of his neural placode. The neural placode was circumnavigated and placed in the neural canal. A dural sleeve was fashioned in such a way to reconstruct the neural tube geometry.
This anteroposterior skull radiograph demonstrates the craniolacunia or Luckenschadel seen in patients with myelomeningocele and hydrocephalus. Mesodermal dysplastic changes cause defects in the bone. The thin ovoid areas of calvaria are often surrounded by dense bone deposits. They are most likely the result of defective membranous bone formation typical of neural tube defects and not increased intracranial pressure as once thought. These characteristic honeycomb changes are seen in about 80% of the skulls in children with myelomeningocele and hydrocephalus.
Sagittal T1-weighted MRI image of a child after closure of his myelomeningocele. Child is aged 7 years. Note the spinal cord ends in the sacral region far below the normal level of T12-L1. It is tethered at the point in which the neural placode was attached to the skin defect during gestation. The MRI showed dorsal tethering, and the child complained of back pain and had a new foot deformity on examination. By definition, all children with a myelomeningocele have a tethered cord on MRI, but only about 20% of children require an operation to untether the spinal cord during their first decade of life, during their rapid growth spurts. Thus, the MRI must be placed in context of a history and examination consistent with mechanical tethering and a resultant neurologic deterioration.
Sagittal T1 MRI image of a child with a myelomeningocele and associated Chiari II malformation. Note the cerebellar vermis and part of the brainstem has herniated below the foramen magnum and into the cervical canal (arrow). This patient had multiple brainstem symptoms and findings to include stridor and cranial nerve paresis (cranial nerves III, VI, IX, X) despite having a well-functioning ventricular-peritoneal shunt. He required a posterior fossa decompression of his hindbrain in order to relieve the symptoms of hindbrain herniation and brainstem compression. A minority of myelomeningocele patients require a Chiari II decompression. Those that do usually present in their first year of life with similar symptoms, stridor and cranial nerve paresis. A functioning shunt is imperative prior to exploring the posterior fossa in these children. Often times, especially in older children, a shunt revision may alleviate some of the symptoms of hindbrain compression.
Neonate with a large occipital encephalocele lying in the prone position prior to surgical intervention. Note the large skin-covered sac that represents a closed neural tube defect. Often called cranium bifidum, it is a more serious condition that represents a failure of the anterior neuropore to close. In this patient, a defect in the skull base (basicranium) was associated with this large sac filled with cerebrospinal fluid and a small, disorganized remnant of brain. The patient fared satisfactorily after the surgery in which the encephalocele was excised. However, the patient needed placement of a ventricular-peritoneal shunt to treat the resultant hydrocephalus, which is not uncommon. At age 5 years, the child was doing well and had only moderate developmental delay.
Autopsy specimen on a child with anencephaly. This is one of the most common CNS malformations in the West. The neonate, like almost all with such a severe forms of neural tube defects, did not survive more than a few hours or days. This malformation represents a failure of the anterior neuropore to close. This photograph also reveals an absence of the calvaria and posterior bone elements of the cervical canal, as well as the deficiency in the prosencephalon. Photo courtesy of Professor Ron Lemire.
Ventral view of a child with anencephaly that, like the previous picture, shows the loss of cranium and enclosed nervous tissue. In addition to the primary defect in development, a secondary destruction of nervous tissue occurs. Direct exposure to the caustic amniotic fluid causes progressive destruction of the remaining neural structures and secondary proliferation of a thin covering of vascular and glial tissue. Photo courtesy of Professor Ron Lemire.
These 2 photographs depict the lumbar regions on 2 different children with closed neural tube defects. Both children have lipomyelomeningocele. The child in the left has a dorsal lipoma that is pedunculated. The child on the right has a more common-appearing lipomatous mass that is heaped up beneath the skin. Both lipomas lead from the subcutaneous tissue, through the dura and into the intradural space, where they are attached to the spinal cord. Photos courtesy of Professor J.D. Loeser.
Photograph of a child undergoing a neurosurgical procedure in which the spinal cord is being detached (untethered) from the intradural and extradural lipomatous mass that fixes it to the subcutaneous tissue. The white arrow shows the laser char on the lipoma that has been shaved off the spinal cord and was connected to the extradural mass. The black arrow shows the extradural lipoma, which crept through the dura and attached to the spinal cord, thereby firmly fixing the spinal cord at too low and too dorsal a location in the sagittal plane.
Table 1. Human CNS Malformations
Days of GestationEventResultant Malformation
0-18Formation of 3 germ layer and neural plateDeath or unclear effect
18Formation of neural plate and groove formAnterior midline defects
22-23Appearance of optic vesselsHydrocephalus (18-60 d)
24-26Close anterior neuroporeAnencephaly
26-28Close posterior neuroporeCranium bifidum, spina bifida cystica, spina bifida occulta
32Vascular circulationMicrocephaly (30-130 d), migration anomalies
33-35Splitting of prosencephalon to make paired telencephalonHoloprosencephaly
70-100Formation of corpus callosumAgenesis of the corpus callosum
Table 2. Anomalies of the CNS Associated with Myelomeningocele
Anomalies Associated with MyelomeningoceleApproximate Percent of Patients
Chiari II malformation>90%
Hydrocephalus>90%
Syringomyelia88%
Brainstem malformations (cranial nerve)75%
Cerebral ventricle abnormalities>90%
Cerebellar heterotopias40%
Cerebral heterotopias40%
Agenesis of the corpus callosum12%
Polymicrogyria15-30%
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.